Results 131 to 140 of about 1,457,629 (200)

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor. [PDF]

open access: yesJ Clin Oncol
Eyre TA   +15 more
europepmc   +1 more source

Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study. [PDF]

open access: yesBr J Haematol, 2023
Hess G   +24 more
europepmc   +1 more source

A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia. [PDF]

open access: yesClin Cancer Res, 2021
An G   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy